Synthesis, Preliminary Anticonvulsant (Electro-Shock) and Acute Oral Toxicity Screening of Substituted-3-Acetyl-2-(substitutedphenyl)-4-methylbenzo[b][1,4]thiazepin-5(2H)-yl)-1-(substitutedphenyl)propan-1-one
Abstract
The current research aimed to synthesize a novel series of 5-substituted mannich bases using the substitution at 5th position at which the hydrogen atom was replaced by two different substituents, p-nitroacetophenone and p-chloroacetophenone having significant anticonvulsant activity. A novel series of substituted-3-acetyl-2-(substitutedphenyl)-4-methylbenzo[b][1,4]thiazepin-5(2H)-yl)-1-(substitutedphenyl)propan-1-one (6a-6t) were synthesized and evaluated for pharmacological activity. A total of 20 compounds, were synthesized by conventional methods and the purity of synthesized compounds were confirmed by melting point and thin layer chromatography (TLC) analysis. Fourier transform infrared (FTIR), proton nuclear magnetic resonance (1H-NMR), mass and elemental analysis characterized the structures of lead compounds. All the novel synthesized compounds (6a-6t) were preliminarily screened by anticonvulsant activity by maximum electroshock induced seizure against phenytoin as a standard drug at a 30 mg/kg dose. In the results of the spectral study, all the compounds showed characteristic peaks in FTIR and 1H-NMR spectroscopy. Compounds containing chlorine moiety show [M+2]+ peak in mass spectrum. In this study all the novel synthesized compounds showed significant anticonvulsant activity. The most significant synthesized compound 3-acetyl-2-(3-chlorophenyl)-4-methylbenzo[b][1,4]thiazepin-5(2H)-yl)-1-(4-chlorophenyl)propan-1-one (6e) found as a primary class of anticonvulsants that have shown practically identical anticonvulsant action with uniquely lower neurotoxicity. Further, the preliminary safety profile of the most potent significant compound (6e) was screened for 'acute oral toxicity' as per organisation for economic co-operation and development (OECD) guidelines, in total fourteen days of observation the normal behavior of animals suggest that compound (6e) was safe and non-toxic in nature. This study suggested further modification and improvement in the field of anticonvulsants drug development.
Keywords:
Acute oral toxicity, Anticonvulsant, Neurotoxicity, Mannich bases, Rota rod assay.DOI
https://doi.org/10.25004/IJPSDR.2022.140608References
Myers CT, Heather CM. Advancing Epilepsy Genetics in the Genomic Myers CT, Heather CM. Advancing Epilepsy Genetics in the Genomic era. Genome Medicine. 2015;7.1: 1-11. Available from: doi: 10.1186/ s13073-015-0214-7
Berkovic SF, John CM, Ingrid ES, Steven P. Human Epilepsies: Interaction of Genetic and Acquired Factors. Trends in Neurosciences. 2006;29.7:391-397. Available from: doi: 10.1016/j.tins.2006.05.009
Reddy RJ, Ashok D, Sharma PN. Synthesis of 4,6-Bis(2'-substituted- 2',3'-dihydro-1,5- benzothiazepines-4'-yl)resorcinols as Potential Antifeedants. Indian Journal of Chemistry. 1993;32B:404-406. Available from: doi:10.1002/chin.199325202
Minako K, Hirotaka I, Hisayoshi D, Mikiko Y, Hiroshi N. Cardiovascular Effects of 1, 5-Benzothiazepine Derivatives having a l-cis and d-cis Configuration in Anesthetized Dogs. Biological and Pharmaceutical Bulletin. 1998;21:50-55. Available from: doi: 10.1248/bpb.21.50
Jeyaprakash RS, Tiwari M, Hashif K, Srinivasan KK. Synthesis and Evaluation of Antimicrobial Activity of Some 2-Substituted Benzimidazole. Pharmacologyonline. 2009;3: 737-742. Available from: doi: 10.3390/molecules200815206
Chaudhri VK, Pathak D, Hussain Z. Synthesis, Preliminary Anticonvulsant and Toxicity Screening of Substituted {1-[4-Methyl- 2-substitutedphenyl-2,5-dihydro-1,5-benzothiazepin-3-yl]- ethylidene}-Hydrazine. Journal of Applied Pharmaceutical Science. 2021;11:16-23. Available from: doi: doi: 10.7324/JAPS.2021.1101003
S a i n i R K , J o s h i Y P. S o l v e n t- F r e e S y n t h e s i s o f S ome 1,5-Benzothiazepines and Benzodiazepines and their Antibacterial Activity. Phosphorous, Sulfur and Silicon and the Related Elements. 2008;183:2181-2190. Available from: doi: https://doi. org/10.1080/10426500701852661
Afzal BS, Yejella RP. Synthesis and Antimicrobial Evaluation of Novel 1,5-Benzothiazepine Derivatives. Journal of International Academy of Physical Sciences. 2021;25:165- 191.
Campiani G, Fiorini I, De F, Ciani SM, Garofalo A, Nacci V, Giorgi G, Sega A, Botta M, Chiarini A, Budriesi R, Bruni G, Romeo MR, Manzoni C, Mennini. Cardiovascular Characterization of Pyrrolo[2,1-d][1,5] benzothiazepine Derivatives Binding Selectively to the Peripheral- Type Benzodiazepine Receptor (PBR): From Dual PBR Affinity and Calcium Antagonist Activity to Novel and Selective Calcium Entry Blockers. Journal of Medicinal Chemistry. 1996;39: 2922-2938. Available from: doi: https://doi.org/10.1021/jm960162z
Falco JL, Pique M, Gonzalez M, Buira I, Mendez, E, Terencio J, Perez C, Princep M, Palomer A, Guglietta A. Synthesis, Pharmacology and Molecular Modeling of N-Substituted 2-Phenyl-indoles and Benzimidazoles as Potent GABAA Agonists. European Journal of Medicinal Chemistry. 2006;41: 985-990. Available from: doi: https:// doi.org/10.1016/j.ejmech.2006.03.031
Genton E, Barnett HJM, Fields WS, Gent M, Hoak XIV. Cerebral Ischemia: the role of Thrombosis and of Antithrombotic Therapy. Study Group on Antithrombotic Therapy. J C Stroke. 1977;8:150-175.
Di SR, Costi R, Artico M, Miele G, Lavecchia A, Novellino E, Bergamini A, Cancio R, Maga G. Arylthiopyrrole (AThP) Derivatives as Non- Nucleoside HIV-1 Reverse Transcriptase Inhibitors: Synthesis, Structure-Activity Relationships, and Docking Studies (Part 1). ChemMedChem. 2006;1:1367-1378. Available from: doi: 10.1002/ cmdc.200600119
Ivorra MD, Lugnier C, Schott C, Catret M, Noguera MA, Anselmi E. Multiple Actions of Glaucine on Cyclic Nucleotide Phosphodiesterases, α1-Adrenoceptor and Benzothiazepine Binding Site at the Calcium Channel. British Journal of Pharmacology.1992;106:387-394. Available from: doi: 10.1111/j.1476-5381.1992.tb14345.x
Muriel A, Isabelle D, Philippe B, Gilbert B, Didier P, Jean LP, Pierre D, Jean M. Design and Synthesis of Potent Bradykinin Agonists Containing a Benzothiazepine Moiety. Journal of Medicinal Chemistry. 1999;42:4185-4192. Available from: doi: https://doi. org/10.1021/jm9901529
Panda SS, Chowdary PV. Synthesis of Novel Indolyl-Pyrimidine Antiinflammatory, Antioxidant and Antibacterial Agents. Indian Journal of Pharmaceutical Sciences. 2008;70:208-215. Available from: doi: 10.4103/0250-474X.41457
Gulhan TZ, Seref D, Ahmet DO, Zafer AK, Mehmet TY. Synthesis of Some 2-[(Benzazole-2-yl)thioacetylamino]thiazole Derivatives and Their Antimicrobial Activity and Toxicity. European Journal of Medicinal Chemistry. 2004;39:267-72. Available from: doi: 10.1016/j.ejmech.2003.11.001.
Raja AS, Pandeya SN, Panda SS, Stables JP. Synthesis and Anticon¬vulsant Evaluation of Semicarbazones of Acetophenone Mannich Bases. Pharmaceutical Chemistry Journal. 2007;41:302-307.
Ameta KL, Rathore NS, Kumar B. Synthesis and Preliminary Evalu¬ation of Novel 1,5-Benzothiazepine Derivatives as Anti-Lung Cancer Agents. International Journal of Pharmaceutics. 2013;3:328-333.
Ansari FL, Iftikhar F, Iulhaq B, Mirza M, Baseer UR. Solid Phase Syn¬thesis and Biological Evaluation of Parallel Library of 2,3-dihydro- 1,5-Benzothiazepene. Bioorganic & Medicinal Chemistry. 2008; 16:7691-7697. Available from: doi: 10.1016/j.bmc.2008.07.009
Bhrigu B, Siddiqui N, Pathak D, Alam Md S. Anticonvulsant evalua¬tion of some newer benzimidazole derivatives: Design and synthe¬sis. ACTA POLONIAE PHARMACEUTICA. 2012;69:53-62.
OECD, Test No. 420: Acute Oral Toxicity-Fixed Dose Procedure. OECD Guidelines for the Testing of Chemicals. Organization for Economic Cooperation and Development. Paris, France, 2001.
Khatoon Y, Shaquiquzzaman M, Singh V, Sarafroz M. Synthesis, Anticonvulsant and Neurotoxicity Screening of Some Novel 2,5-Dis-ubstituted-1,3,4-Oxadiazole Derivatives. International Journal of Pharmaceutical Sciences and Research. 2017;9:22-29. Available from: doi: https://doi.org/10.25004/IJPSDR.2017.090104
Kulkarni SK. Hand book of Experimental Pharmacology. Vallabh Prakashan, New Delhi, 2011.
Yadav MK, Singh BK, Tripathi L. Synthesis and Bioactivity of 3-(1-alkyl-4-aryl-6-thioxo-1,6-dihydro-1,3,5-trizazin-2-yl)-amino- 2-aryl-3,4-dihydro-4-oxo-2h-1,3-benzothiazines. International Journal of Current Research. 2016;8:35285-35288.
Pandeya SN, Kohali S, Siddique N, Stables JP. Synthesis and Anticonvulsant Activities of 4-N-Substituted Arylsemicarbazones. Polish journal of pharmacology. 2003;55:565-571.
Tripathi KD. Essentials of Medical Pharmacology. Jaypee Brothers, New Delhi, 2004.
Siddiqui N, Singh PK, Kumar N, Pathak D. Synthesis and Evaluation of 1-(2-(Substituted benzylidenehydrazinyl)acetyl)-3-(hydroxyimino) indolin-2-one as Potential Anticonvulsants. Der Pharmacia Sinica. 2015;6:30-40.
Porwal M, Khan NA, Maheshwari KK. Evaluation of Acute and Subacute Oral Toxicity Induced by Ethanolic Extract of Marsdenia Tenacissima Leaves in Experimental Rats. Sci Pharm. 2017;85:1-11. Available from: doi: 10.3390/scipharm85030029
Ali R, Siddiqui N. Preliminary Anticonvulsant and Toxicity Screening of Substituted Benzylidenehydrazinyl-N-(6-substituted benzo[d] thiazol-2-yl)propanamides. Scientific World Journal. 2014;1-10. Available from: doi: https://doi.org/10.1155/2014/194652
Jonsson M, Jestoi M, Nathanail AV, Kokkonen UM, Koivisto MAP, Karhunen P, Peltonen K. Application of OECD Guideline 423 in Assessing the Acute Oral Toxicity of Moniliformin. Food and Chemical Toxicology. 2013;53:27-32. Available from: doi: 10.1016/j. fct.2012.11.023
Published
Abstract Display: 411 
PDF Downloads: 396 
